>
pdufa.bio

REOLYSIN

Updated ยทnext FDA decision on the calendar

REOLYSIN is a Oncolytics Biotech Inc program. Its next catalyst is a Readout in Jul 2027. Every date links its source.

ONCY catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Oncolytics Biotech Inc (ONCY). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2027ONCY

Questions

When is REOLYSIN's next FDA decision or readout?

The next tracked catalyst for REOLYSIN is a Readout in Jul 2027.

What happened at REOLYSIN's most recent FDA decision?

No FDA decision for REOLYSIN is in our archive yet.

Who makes REOLYSIN?

Oncolytics Biotech Inc (ONCY).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.